Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1998 Mar;152(3):641–644.

Production of interleukin-6 by synovial fibroblasts in rheumatoid arthritis.

H Baumann 1, I Kushner 1
PMCID: PMC1858408  PMID: 9502403

Full text

PDF
641

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aono H., Hasunuma T., Fujisawa K., Nakajima T., Yamamoto K., Mita S., Nishioka K. Direct suppression of human synovial cell proliferation in vitro by salazosulfapyridine and bucillamine. J Rheumatol. 1996 Jan;23(1):65–70. [PubMed] [Google Scholar]
  2. Auphan N., DiDonato J. A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 1995 Oct 13;270(5234):286–290. doi: 10.1126/science.270.5234.286. [DOI] [PubMed] [Google Scholar]
  3. Badolato R., Oppenheim J. J. Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis. Semin Arthritis Rheum. 1996 Oct;26(2):526–538. doi: 10.1016/s0049-0172(96)80041-2. [DOI] [PubMed] [Google Scholar]
  4. Baffet G., Braciak T. A., Fletcher R. G., Gauldie J., Fey G. H., Northemann W. Autocrine activity of interleukin 6 secreted by hepatocarcinoma cell lines. Mol Biol Med. 1991 Feb;8(1):141–156. [PubMed] [Google Scholar]
  5. Berek C., Kim H. J. B-cell activation and development within chronically inflamed synovium in rheumatoid and reactive arthritis. Semin Immunol. 1997 Aug;9(4):261–268. doi: 10.1006/smim.1997.0076. [DOI] [PubMed] [Google Scholar]
  6. Bucala R., Ritchlin C., Winchester R., Cerami A. Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med. 1991 Mar 1;173(3):569–574. doi: 10.1084/jem.173.3.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Burmester G. R., Stuhlmüller B., Keyszer G., Kinne R. W. Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? Arthritis Rheum. 1997 Jan;40(1):5–18. doi: 10.1002/art.1780400104. [DOI] [PubMed] [Google Scholar]
  8. De Benedetti F., Alonzi T., Moretta A., Lazzaro D., Costa P., Poli V., Martini A., Ciliberto G., Fattori E. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest. 1997 Feb 15;99(4):643–650. doi: 10.1172/JCI119207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. De Benedetti F., Ravelli A., Martini A. Cytokines in juvenile rheumatoid arthritis. Curr Opin Rheumatol. 1997 Sep;9(5):428–433. doi: 10.1097/00002281-199709000-00009. [DOI] [PubMed] [Google Scholar]
  10. De Bosscher K., Schmitz M. L., Vanden Berghe W., Plaisance S., Fiers W., Haegeman G. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13504–13509. doi: 10.1073/pnas.94.25.13504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dechanet J., Rissoan M. C., Banchereau J., Miossec P. Interleukin 4, but not interleukin 10, regulates the production of inflammation mediators by rheumatoid synoviocytes. Cytokine. 1995 Feb;7(2):176–183. doi: 10.1006/cyto.1995.1024. [DOI] [PubMed] [Google Scholar]
  12. Dendorfer U., Oettgen P., Libermann T. A. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol. 1994 Jul;14(7):4443–4454. doi: 10.1128/mcb.14.7.4443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Donnelly R. P., Crofford L. J., Freeman S. L., Buras J., Remmers E., Wilder R. L., Fenton M. J. Tissue-specific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-kappa B activity in monocytes and fibroblasts. J Immunol. 1993 Nov 15;151(10):5603–5612. [PubMed] [Google Scholar]
  14. Edwards S. W., Hallett M. B. Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol Today. 1997 Jul;18(7):320–324. doi: 10.1016/s0167-5699(97)01087-6. [DOI] [PubMed] [Google Scholar]
  15. Fattori E., Cappelletti M., Costa P., Sellitto C., Cantoni L., Carelli M., Faggioni R., Fantuzzi G., Ghezzi P., Poli V. Defective inflammatory response in interleukin 6-deficient mice. J Exp Med. 1994 Oct 1;180(4):1243–1250. doi: 10.1084/jem.180.4.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Feder L. S., Todaro J. A., Laskin D. L. Characterization of interleukin-1 and interleukin-6 production by hepatic endothelial cells and macrophages. J Leukoc Biol. 1993 Feb;53(2):126–132. doi: 10.1002/jlb.53.2.126. [DOI] [PubMed] [Google Scholar]
  17. Feldmann M., Brennan F. M., Maini R. N. Rheumatoid arthritis. Cell. 1996 May 3;85(3):307–310. doi: 10.1016/s0092-8674(00)81109-5. [DOI] [PubMed] [Google Scholar]
  18. Feldmann M., Brennan F. M., Maini R. N. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397–440. doi: 10.1146/annurev.immunol.14.1.397. [DOI] [PubMed] [Google Scholar]
  19. Firestein G. S. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum. 1996 Nov;39(11):1781–1790. doi: 10.1002/art.1780391103. [DOI] [PubMed] [Google Scholar]
  20. Gauldie J., Northemann W., Fey G. H. IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6. J Immunol. 1990 May 15;144(10):3804–3808. [PubMed] [Google Scholar]
  21. Guerne P. A., Zuraw B. L., Vaughan J. H., Carson D. A., Lotz M. Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest. 1989 Feb;83(2):585–592. doi: 10.1172/JCI113921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Handel M. L., McMorrow L. B., Gravallese E. M. Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. Arthritis Rheum. 1995 Dec;38(12):1762–1770. doi: 10.1002/art.1780381209. [DOI] [PubMed] [Google Scholar]
  23. Hoy M. D., Williams J. L., Kirkham B. W. Symmetrical synovial fluid cell cytokine messenger RNA expression in rheumatoid arthritis: analysis by reverse transcription/polymerase chain reaction. Br J Rheumatol. 1997 Feb;36(2):170–173. doi: 10.1093/rheumatology/36.2.170. [DOI] [PubMed] [Google Scholar]
  24. Ivashkiv L. B. Cytokine expression and cell activation in inflammatory arthritis. Adv Immunol. 1996;63:337–376. doi: 10.1016/s0065-2776(08)60859-7. [DOI] [PubMed] [Google Scholar]
  25. Kannabiran C., Zeng X., Vales L. D. The mammalian transcriptional repressor RBP (CBF1) regulates interleukin-6 gene expression. Mol Cell Biol. 1997 Jan;17(1):1–9. doi: 10.1128/mcb.17.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kingsley G., Panayi G. S. Joint destruction in rheumatoid arthritis: biological bases. Clin Exp Rheumatol. 1997 May-Jun;15 (Suppl 17):S3–14. [PubMed] [Google Scholar]
  27. Kinne R. W., Palombo-Kinne E., Emmrich F. T-cells in the pathogenesis of rheumatoid arthritis villains or accomplices? Biochim Biophys Acta. 1997 Apr 12;1360(2):109–141. doi: 10.1016/s0925-4439(96)00079-8. [DOI] [PubMed] [Google Scholar]
  28. Kotake S., Sato K., Kim K. J., Takahashi N., Udagawa N., Nakamura I., Yamaguchi A., Kishimoto T., Suda T., Kashiwazaki S. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res. 1996 Jan;11(1):88–95. doi: 10.1002/jbmr.5650110113. [DOI] [PubMed] [Google Scholar]
  29. Kunkel S. L., Lukacs N., Kasama T., Strieter R. M. The role of chemokines in inflammatory joint disease. J Leukoc Biol. 1996 Jan;59(1):6–12. doi: 10.1002/jlb.59.1.6. [DOI] [PubMed] [Google Scholar]
  30. Mantovani L., Henschler R., Brach M. A., Wieser R., Lübbert M., Lindemann A., Mertelsmann R. H., Herrmann F. Differential regulation of interleukin-6 expression in human fibroblasts by tumor necrosis factor-alpha and lymphotoxin. FEBS Lett. 1990 Sep 17;270(1-2):152–156. doi: 10.1016/0014-5793(90)81256-n. [DOI] [PubMed] [Google Scholar]
  31. Marok R., Winyard P. G., Coumbe A., Kus M. L., Gaffney K., Blades S., Mapp P. I., Morris C. J., Blake D. R., Kaltschmidt C. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum. 1996 Apr;39(4):583–591. doi: 10.1002/art.1780390407. [DOI] [PubMed] [Google Scholar]
  32. Mihara M., Moriya Y., Kishimoto T., Ohsugi Y. Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol. 1995 Apr;34(4):321–325. doi: 10.1093/rheumatology/34.4.321. [DOI] [PubMed] [Google Scholar]
  33. Mihara M., Moriya Y., Ohsugi Y. IL-6-soluble IL-6 receptor complex inhibits the proliferation of dermal fibroblasts. Int J Immunopharmacol. 1996 Jan;18(1):89–94. doi: 10.1016/0192-0561(95)00106-9. [DOI] [PubMed] [Google Scholar]
  34. Miyazawa K., Mori A., Yamamoto K., Okudaira H. Constitutive transcription of the human interleukin-6 gene by rheumatoid synoviocytes: spontaneous activation of NF-kappaB and CBF1. Am J Pathol. 1998 Mar;152(3):793–803. [PMC free article] [PubMed] [Google Scholar]
  35. Muraoka K., Fujimoto K., Sun X., Yoshioka K., Shimizu K., Yagi M., Bose H., Jr, Miyazaki I., Yamamoto K. Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-kappa(B). Implications for FK506 nephropathy. J Clin Invest. 1996 Jun 1;97(11):2433–2439. doi: 10.1172/JCI118690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Müller-Ladner U., Gay R. E., Gay S. Cellular pathways of joint destruction. Curr Opin Rheumatol. 1997 May;9(3):213–220. doi: 10.1097/00002281-199705000-00007. [DOI] [PubMed] [Google Scholar]
  37. Nakayama K., Shimizu H., Mitomo K., Watanabe T., Okamoto S., Yamamoto K. A lymphoid cell-specific nuclear factor containing c-Rel-like proteins preferentially interacts with interleukin-6 kappa B-related motifs whose activities are repressed in lymphoid cells. Mol Cell Biol. 1992 Apr;12(4):1736–1746. doi: 10.1128/mcb.12.4.1736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Okamoto H., Yamamura M., Morita Y., Harada S., Makino H., Ota Z. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Arthritis Rheum. 1997 Jun;40(6):1096–1105. doi: 10.1002/art.1780400614. [DOI] [PubMed] [Google Scholar]
  39. Ray A., LaForge K. S., Sehgal P. B. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol Cell Biol. 1990 Nov;10(11):5736–5746. doi: 10.1128/mcb.10.11.5736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ray A., Prefontaine K. E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):752–756. doi: 10.1073/pnas.91.2.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ray A., Tatter S. B., May L. T., Sehgal P. B. Activation of the human "beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6701–6705. doi: 10.1073/pnas.85.18.6701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ray A., Zhang D. H., Siegel M. D., Ray P. Regulation of interleukin-6 gene expression by steroids. Ann N Y Acad Sci. 1995 Jul 21;762:79–88. doi: 10.1111/j.1749-6632.1995.tb32316.x. [DOI] [PubMed] [Google Scholar]
  43. Richards C. D., Agro A. Interaction between oncostatin M, interleukin 1 and prostaglandin E2 in induction of IL-6 expression in human fibroblasts. Cytokine. 1994 Jan;6(1):40–47. doi: 10.1016/1043-4666(94)90006-x. [DOI] [PubMed] [Google Scholar]
  44. Ritchlin C., Dwyer E., Bucala R., Winchester R. Sustained and distinctive patterns of gene activation in synovial fibroblasts and whole synovial tissue obtained from inflammatory synovitis. Scand J Immunol. 1994 Sep;40(3):292–298. doi: 10.1111/j.1365-3083.1994.tb03465.x. [DOI] [PubMed] [Google Scholar]
  45. Scheinman R. I., Cogswell P. C., Lofquist A. K., Baldwin A. S., Jr Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 1995 Oct 13;270(5234):283–286. doi: 10.1126/science.270.5234.283. [DOI] [PubMed] [Google Scholar]
  46. Seitz M., Loetscher P., Fey M. F., Tobler A. Constitutive mRNA and protein production of macrophage colony-stimulating factor but not of other cytokines by synovial fibroblasts from rheumatoid arthritis and osteoarthritis patients. Br J Rheumatol. 1994 Jul;33(7):613–619. doi: 10.1093/rheumatology/33.7.613. [DOI] [PubMed] [Google Scholar]
  47. Shimizu H., Mitomo K., Watanabe T., Okamoto S., Yamamoto K. Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol Cell Biol. 1990 Feb;10(2):561–568. doi: 10.1128/mcb.10.2.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sugiyama E., Kuroda A., Taki H., Ikemoto M., Hori T., Yamashita N., Maruyama M., Kobayashi M. Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J Rheumatol. 1995 Nov;22(11):2020–2026. [PubMed] [Google Scholar]
  49. Tan P. L., Farmiloe S., Yeoman S., Watson J. D. Expression of the interleukin 6 gene in rheumatoid synovial fibroblasts. J Rheumatol. 1990 Dec;17(12):1608–1612. [PubMed] [Google Scholar]
  50. Tilg H., Dinarello C. A., Mier J. W. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today. 1997 Sep;18(9):428–432. doi: 10.1016/s0167-5699(97)01103-1. [DOI] [PubMed] [Google Scholar]
  51. Tobler A., Meier R., Seitz M., Dewald B., Baggiolini M., Fey M. F. Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood. 1992 Jan 1;79(1):45–51. [PubMed] [Google Scholar]
  52. Tsujinaka T., Fujita J., Ebisui C., Yano M., Kominami E., Suzuki K., Tanaka K., Katsume A., Ohsugi Y., Shiozaki H. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest. 1996 Jan 1;97(1):244–249. doi: 10.1172/JCI118398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Wagner S., Fritz P., Einsele H., Sell S., Saal J. G. Evaluation of synovial cytokine patterns in rheumatoid arthritis and osteoarthritis by quantitative reverse transcription polymerase chain reaction. Rheumatol Int. 1997;16(5):191–196. doi: 10.1007/BF01330295. [DOI] [PubMed] [Google Scholar]
  54. Wang P., Wu P., Siegel M. I., Egan R. W., Billah M. M. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem. 1995 Apr 21;270(16):9558–9563. doi: 10.1074/jbc.270.16.9558. [DOI] [PubMed] [Google Scholar]
  55. Woo P. The cytokine network in juvenile chronic arthritis. Ann Med. 1997 Apr;29(2):145–147. doi: 10.3109/07853899709113701. [DOI] [PubMed] [Google Scholar]
  56. Xia D., Samols D. Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2575–2580. doi: 10.1073/pnas.94.6.2575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Yamamoto T., Nishiura H., Nishida H. Molecular mechanisms to form leukocyte infiltration patterns distinct between synovial tissue and fluid of rheumatoid arthritis. Semin Thromb Hemost. 1996;22(6):507–511. doi: 10.1055/s-2007-999052. [DOI] [PubMed] [Google Scholar]
  58. Zhang Y. H., Lin J. X., Vilcek J. Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence. Mol Cell Biol. 1990 Jul;10(7):3818–3823. doi: 10.1128/mcb.10.7.3818. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES